Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > "Nitrogen Scavenging Properties"
View:
Post by 37minus4 on Mar 14, 2022 8:18am

"Nitrogen Scavenging Properties"

Well that is some thin gruel, boy.

Maybe they can add some of their "scavenged nitrogen" to the poutine in the poutine shack.

Tasty.

;-/

33
Comment by stockbuphoon on Mar 14, 2022 10:00am
This study result was 100% telegraphed and expected that they would tank 4050 despite the early success in fibrosis on Alstrom and IPF. So, someone is lying. Was it previous management of Pierre Laurin and Dr John Moran or was it Thomvest / current management who recapitalized PLi? With many trials completed previously with top scientists, they found strong fibrosis candidates. Now, with a ...more  
Comment by PLITheOne on Mar 14, 2022 3:19pm
Liminal's job is to make as much money and profit as they can for Thomvest, their owners, that’s business 101.  If they need to misinform, misrepresent, and distort reality to accomplish their outcome they will. If it's better for them to screw investors they will without a second thought. If it's better to twist the branding of PBI 4050 to disconnect themselves from this ...more  
Comment by PLITheOne on Mar 14, 2022 3:22pm
Thomvest had much more intel to the potential of Prometic and they wanted in and continued to invest for many years! WHY!?  They'll never tell you or share any profits with peeon retail investors  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities